AstraZeneca mulls spinning off China activities: FT

Posted on

astrazeneca

Anglo-Swedish drugmaker AstraZeneca could spin off its Chinese division and list it in Hong Kong to minimize China-related risks, the Financial Times reported on Monday.

The company started discussions several months ago, the business daily said citing people familiar with the talks.

AstraZeneca declined to comment.

According to the FT, the drugmaker was seeking to diminish the risk of any potential Chinese crackdown on foreign companies.

© 2023 AFP

Source: Read Full Article

Related posts:
  1. Sepsis test being trialled for newborn babies could miss 30% of cases
  2. Nearly 500K Aetna members affected by EyeMed security incident
  3. Good Survival, Outcomes With TARE for HCC
  4. Innate and adaptive immune responses to BNT162b2 vaccination in mice
  5. Study proves that antivenom reduces risk of skin necrosis in patients bitten by brown recluse spider
Related posts